Back to Search

Brexucabtagene Autoleucel 1 × 10⁶ anti-CD19 CAR-positive viable T cells/kg (Maximum allowable dos – Uses, Dosage, and Brands in UAE

Brand Name: TECARTUS
Strength: 1 × 10⁸ anti CD-19 CAR positive viable T cells based on patient weight 100 KG) : 1000000 C/1 Bag | Form:
Price in UAE: AED 1924694.00
Available in UAE pharmacies

About Brexucabtagene Autoleucel 1 × 10⁶ anti-CD19 CAR-positive viable T cells/kg (Maximum allowable dos

Class: | CAR T-cell therapy Use: | Treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least one prior therapy Adult dose: | 1 × 10⁶ anti-CD19 CAR-positive viable T cells/kg (maximum dose of 1 × 10⁸ anti-CD19 CAR-positive viable T cells based on patient weight) Pediatric dose: | Safety and efficacy not established in pediatric patients Side effects: | Cytokine release syndrome (CRS), neurological toxicities (including encephalopathy), infections, h

Drug Class

CAR T-cell therapy

Uses & Indications

Treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least one prior therapy

Storage Requirements

Store at -196°C in the vapor phase of liquid nitrogen; do not thaw until ready to use

Manufacturer & Packaging

Manufacturer: GILEAD SCIENCES IRELAND UC (CARRIGTOHILL-IRELAND), Ireland

Package Size

Bag

Price & Supplier

Price in UAE: AED 1924694.00

Dosage Information

Adult Dose

1 × 10⁶ anti-CD19 CAR-positive viable T cells/kg (maximum dose of 1 × 10⁸ anti-CD19 CAR-positive viable T cells based on patient weight)

Pediatric Dose

Safety and efficacy not established in pediatric patients

Side Effects

Cytokine release syndrome (CRS), neurological toxicities (including encephalopathy), infections, hypogammaglobulinemia, and infusion-related reactions

Contraindications & Precautions

Hypersensitivity to any component of the product; active uncontrolled infection; severe pre-existing neurological conditions

Important Warnings

Risk of CRS and neurological toxicities; monitor patients closely for signs of these conditions; ensure availability of supportive care and treatment for CRS (e.g., tocilizumab)

Related Medicines in Same Category

See also: Other CAR T-cell therapy medicines available in UAE pharmacies

Axicabtagene ciloleucel 1 × 10⁶ – 2 × 10⁶ CAR T cells/kg to a maximum allowable dose of 2 × 10⁸ CAR T cells per Bag (approximately 68 mL) Brexucabtagene Autoleucel 2 × 10 ⁶ anti CD19 CAR-positive viable T cells /kg (Maximum allowable dose 2 × 10 ⁶ anti CD19 CAR-positive viable T cells based on patient weight 100 kg)

Medical Disclaimer

This information is for educational purposes only and should not replace professional medical advice. Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. The information presented here is specific to medicines available in UAE pharmacies and is regularly updated to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.

View All CAR T-cell therapy Medicines Browse All Categories